4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-112325
Director sold 29,941 shares at an average $35.32 ($1,057,460)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kersten Dirk Director | 2024-10-01 | Sale 10b5-1 | −8,423 | $35.16 | $296,153 | 150,282 | I: show line 1 in the form |
| Kersten Dirk Director | 2024-10-02 | Sale 10b5-1 | −21,518 | $35.38 | $761,307 | 128,764 | I: show line 2 in the form |
| Open-market sales · 29,941 sh · avg $35.32 · $1,057,460 | |||||||
Loading xslF345X05/ownership.xml…